Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system

Commun Biol. 2024 Jul 31;7(1):921. doi: 10.1038/s42003-024-06610-x.

Philipp A Ilinykh^{1

2}, Kai Huang^{1

2}, Bronwyn M Gunn³, Natalia A Kuzmina^{1

2}, Kritika Kedarinath^{1

2}, Eduardo Jurado-Cobena^{1

2}, Fuchun Zhou^{1

2}, Chandru Subramani^{1

2}, Matthew A Hyde², Jalene V Velazquez⁴, Lauren E Williamson⁵, Pavlo Gilchuk⁵, Robert H Carnahan^{5

6}, Galit Alter⁷, James E Crowe Jr^{8

9

10}, Alexander Bukreyev^{11

12

13}

¹ Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
² Galveston National Laboratory, Galveston, TX, USA.
³ Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
⁴ Paul G. Allen School of Global Health, Washington State University, Pullman, WA, USA.
⁵ Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
⁶ Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
⁷ Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. Galit.Alter@modernatx.com.
⁸ Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.
⁹ Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.
¹⁰ Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.
¹¹ Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA. alexander.bukreyev@utmb.edu.
¹² Galveston National Laboratory, Galveston, TX, USA. alexander.bukreyev@utmb.edu.
¹³ Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. alexander.bukreyev@utmb.edu.

No abstract available

Publication types